CUVLVSSGRX• 12 Months (Normalized)
CUVL vs SGRX (Clinuvel Pharmaceuticals Limited vs SANGRIX INC.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CUVL Performance $5.95
-4.03%
Clinuvel Pharmaceuticals Limited
Normalized Baseline0.00%
SGRX Performance $1.68
-98.74%
SANGRIX INC.
Normalized Baseline0.00%
Alpha Spread Margin CUVL LEADS
+94.71%
CUVL outperforming by 94.71%
CUVLSGRX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CUVL SGRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CUVL Price | CUVL Gain (%) | SGRX Price | SGRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $5.95 | -4.03% | $1.68 | -98.74% | +94.71% |
| Sep 10, 2026 | $5.88 | -5.16% | $1.43 | -98.93% | +93.77% |
| Sep 09, 2026 | $5.93 | -4.35% | $1.66 | -98.76% | +94.41% |
| Sep 08, 2026 | $6.01 | -3.06% | $1.64 | -98.77% | +95.71% |
| Sep 04, 2026 | $6.52 | +5.16% | $2.10 | -98.43% | +103.59% |
| Sep 03, 2026 | $6.28 | +1.29% | $2.21 | -98.35% | +99.64% |
| Sep 02, 2026 | $6.20 | +0.00% | $2.32 | -98.27% | +98.27% |
| Sep 01, 2026 | $- | $2.58 | -98.07% | - | |
| Aug 31, 2026 | $- | $2.77 | -97.93% | - | |
| Aug 28, 2026 | $- | $3.10 | -97.68% | - | |
| Aug 27, 2026 | $- | $3.55 | -97.35% | - | |
| Aug 26, 2026 | $- | $3.42 | -97.44% | - | |
| Aug 25, 2026 | $- | $3.62 | -97.29% | - | |
| Aug 24, 2026 | $- | $3.32 | -97.52% | - | |
| Aug 21, 2026 | $- | $3.73 | -97.21% | - |
Page 1 of 17